Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT04541160
Eligibility Criteria:
Inclusion Criteria:
* Suspected CAP;
* At least one respiratory symptom (new or increasing cough, expectoration, dyspnea or chest pain) and
* At least one symptom related to infection (fever ≥ 38°C, chills, sweating, myalgia, mental confusion or headache) and
* Focal auscultatory findings during physical examinations (crackling rales)
* No definitive diagnosis possible by clinical judgment.
Exclusion Criteria:
* Score in at least one clinical part of the CURB-65 or PSA scores
* Clinical diagnosis of rhinosinusitis and acute nasopharyngitis and who had already been treated with antimicrobial therapy for this episode of disease
* pregnancy;
* the presence of other respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, chronic diseases or other chronic airway conditions;
* diagnosis of congestive heart failure;
* body mass index (BMI) greater than 30;
* inability to hold the breath for at least 10 seconds
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04541160
Study Brief:
Protocol Section:
NCT04541160